Skip to navigation Skip to content

Current Advocacy Issues

Explore and take action on hot issues.

Share

Master Page Does Not Exist

 

Master Page Does Not Exist

Oregon 2020 Legislation

Streamline Step Utilization Management (step therapy and prior authorizations)
Introduced 1.27.2020 – Passed House 2.20.2020 – At Desk upon adjournment (died) 3.8.2020
The National Multiple Sclerosis Society, Oregon Chapter, supports efforts to base treatment decisions on research and medical expertise rather than cost alone

Oregon Medical Association Position Statement 

Cost of Prescription Drugs, Rebates and Markup Transparency
Introduced 1.27.2020 – Passed Senate 2.20.2020 – At Desk upon adjournment (died) 3.8.2020
The National Multiple Sclerosis Society, Greater Northwest Chapter, supports efforts in continuing to make the cost of medications more transparent for all consumers with high costs.

Monitor

Implementation on Pharmacy Benefit Manager Requirements
Introduced 1.27.2020 – Passed House 2.14.2020 – At Desk upon adjournment (died) 3.8.2020
The National Multiple Sclerosis Society, Oregon Chapter, monitors regulator efforts which impact access to medications for those living with MS.

Oregon Legislative Page – HB 4030

Staff Measure Summary

2019 Legislation  

Master Page Does Not Exist

Share


Chapter Home Advocate for Change
Master Page Does Not Exist
Master Page Does Not Exist
© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.